{"entity":{"type":"insider","cik":"0001847919","url":"/insider/0001847919","json_url":"/insider/0001847919.json","name":"Rodriguez Javier","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":9,"n_filings":8,"first":"2023-03-16","last":"2026-05-22","span_basis":"filed_date"},"name_variants":[{"name":"Rodriguez Javier","source":"filing","n_filings":8,"first_seen":"2023-03-16","last_seen":"2026-05-22"}],"transactions":[{"id":5892854,"accession":"0001104659-26-065839","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001104659-26-065839","line_url":"/filing/0001104659-26-065839#line-2","is_derivative":false,"issuer_cik":"0001720893","issuer_name":"BioXcel Therapeutics, Inc.","issuer_ticker":"BTAI","issuer_name_source":null,"issuer_url":"/issuer/0001720893","owner_cik":"0001847919","owner_name":"Rodriguez Javier","owner_display_name":"Rodriguez Javier","owner_url":"/insider/0001847919","role":"Officer","role_mark":"O","role_mark_label":"Officer","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"See Remarks","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":6560.0,"shares_display":"6,560","price_per_share":1.084,"price_display":"1.08","price_state":"stated","total_value":7111.04,"total_display":"7,111.04","total_whole":"7,111","shares_owned_after":26803.0,"shares_owned_after_display":"26,803","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-05-20","filed_date":"2026-05-22","scope":"insider"},{"id":2052067,"accession":"0001104659-24-129458","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001104659-24-129458","line_url":"/filing/0001104659-24-129458","is_derivative":false,"issuer_cik":"0001720893","issuer_name":"BioXcel Therapeutics, Inc.","issuer_ticker":"BTAI","issuer_name_source":null,"issuer_url":"/issuer/0001720893","owner_cik":"0001847919","owner_name":"Rodriguez Javier","owner_display_name":"Rodriguez Javier","owner_url":"/insider/0001847919","role":"Officer","role_mark":"O","role_mark_label":"Officer","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"See Remarks","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":430.0,"shares_display":"430","price_per_share":0.35586976744186044,"price_display":"0.36","price_state":"stated","total_value":153.024,"total_display":"153.02","total_whole":"153","shares_owned_after":24423.0,"shares_owned_after_display":"24,423","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-12-16","filed_date":"2024-12-17","scope":"insider","n_lines":2},{"id":3022756,"accession":"0001104659-24-106063","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001104659-24-106063","line_url":"/filing/0001104659-24-106063#line-2","is_derivative":false,"issuer_cik":"0001720893","issuer_name":"BioXcel Therapeutics, Inc.","issuer_ticker":"BTAI","issuer_name_source":null,"issuer_url":"/issuer/0001720893","owner_cik":"0001847919","owner_name":"Rodriguez Javier","owner_display_name":"Rodriguez Javier","owner_url":"/insider/0001847919","role":"Officer","role_mark":"O","role_mark_label":"Officer","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"See Remarks","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":6863.0,"shares_display":"6,863","price_per_share":0.55,"price_display":"0.55","price_state":"stated","total_value":3774.65,"total_display":"3,774.65","total_whole":"3,775","shares_owned_after":23770.0,"shares_owned_after_display":"23,770","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-10-03","filed_date":"2024-10-03","scope":"insider"},{"id":2051775,"accession":"0001104659-24-100748","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001104659-24-100748","line_url":"/filing/0001104659-24-100748#line-3","is_derivative":false,"issuer_cik":"0001720893","issuer_name":"BioXcel Therapeutics, Inc.","issuer_ticker":"BTAI","issuer_name_source":null,"issuer_url":"/issuer/0001720893","owner_cik":"0001847919","owner_name":"Rodriguez Javier","owner_display_name":"Rodriguez Javier","owner_url":"/insider/0001847919","role":"Officer","role_mark":"O","role_mark_label":"Officer","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"See Remarks","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":345.0,"shares_display":"345","price_per_share":0.69,"price_display":"0.69","price_state":"stated","total_value":238.05,"total_display":"238.05","total_whole":"238","shares_owned_after":9133.0,"shares_owned_after_display":"9,133","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-09-16","filed_date":"2024-09-17","scope":"insider"},{"id":2435000,"accession":"0001104659-24-073001","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001104659-24-073001","line_url":"/filing/0001104659-24-073001#line-3","is_derivative":false,"issuer_cik":"0001720893","issuer_name":"BioXcel Therapeutics, Inc.","issuer_ticker":"BTAI","issuer_name_source":null,"issuer_url":"/issuer/0001720893","owner_cik":"0001847919","owner_name":"Rodriguez Javier","owner_display_name":"Rodriguez Javier","owner_url":"/insider/0001847919","role":"Officer","role_mark":"O","role_mark_label":"Officer","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"See Remarks","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":361.0,"shares_display":"361","price_per_share":1.2632,"price_display":"1.26","price_state":"stated","total_value":456.0152,"total_display":"456.02","total_whole":"456","shares_owned_after":8394.0,"shares_owned_after_display":"8,394","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-06-17","filed_date":"2024-06-18","scope":"insider"},{"id":2246856,"accession":"0001104659-24-044858","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001104659-24-044858","line_url":"/filing/0001104659-24-044858#line-3","is_derivative":false,"issuer_cik":"0001720893","issuer_name":"BioXcel Therapeutics, Inc.","issuer_ticker":"BTAI","issuer_name_source":null,"issuer_url":"/issuer/0001720893","owner_cik":"0001847919","owner_name":"Rodriguez Javier","owner_display_name":"Rodriguez Javier","owner_url":"/insider/0001847919","role":"Officer","role_mark":"O","role_mark_label":"Officer","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"See Remarks","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1012.0,"shares_display":"1,012","price_per_share":2.6358,"price_display":"2.64","price_state":"stated","total_value":2667.4296,"total_display":"2,667.43","total_whole":"2,667","shares_owned_after":7672.0,"shares_owned_after_display":"7,672","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-04-04","filed_date":"2024-04-08","scope":"insider"},{"id":8145961,"accession":"0001104659-23-061537","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001104659-23-061537","line_url":"/filing/0001104659-23-061537#line-2","is_derivative":false,"issuer_cik":"0001720893","issuer_name":"BioXcel Therapeutics, Inc.","issuer_ticker":"BTAI","issuer_name_source":null,"issuer_url":"/issuer/0001720893","owner_cik":"0001847919","owner_name":"Rodriguez Javier","owner_display_name":"Rodriguez Javier","owner_url":"/insider/0001847919","role":"Officer","role_mark":"O","role_mark_label":"Officer","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"See Remarks","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1785.0,"shares_display":"1,785","price_per_share":27.3192,"price_display":"27.32","price_state":"stated","total_value":48764.772,"total_display":"48,764.77","total_whole":"48,765","shares_owned_after":4350.0,"shares_owned_after_display":"4,350","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-05-15","filed_date":"2023-05-16","scope":"insider"},{"id":8072682,"accession":"0001104659-23-033400","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001104659-23-033400","line_url":"/filing/0001104659-23-033400#line-2","is_derivative":false,"issuer_cik":"0001720893","issuer_name":"BioXcel Therapeutics, Inc.","issuer_ticker":"BTAI","issuer_name_source":null,"issuer_url":"/issuer/0001720893","owner_cik":"0001847919","owner_name":"Rodriguez Javier","owner_display_name":"Rodriguez Javier","owner_url":"/insider/0001847919","role":"Officer","role_mark":"O","role_mark_label":"Officer","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"See Remarks","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":950.0,"shares_display":"950","price_per_share":19.625,"price_display":"19.62","price_state":"stated","total_value":18643.75,"total_display":"18,643.75","total_whole":"18,644","shares_owned_after":1135.0,"shares_owned_after_display":"1,135","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-03-15","filed_date":"2023-03-16","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":9,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":9,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":9},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001720893","name":"BioXcel Therapeutics, Inc.","url":"/issuer/0001720893","role":"Officer","n_filings":8,"first_seen":"2023-03-16","last_seen":"2026-05-22"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001847919","retrieved_at":"2026-08-27T07:45:51+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-26","last_ingest":"2026-08-27T05:24:39.644631+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}